PT1100800E - Novos derivados acetais c-2 s/o e s/n de formaldeido de acidos carbapenem-3-carboxilicos e seu uso como antibioticos e inibidores de beta-lactamase - Google Patents

Novos derivados acetais c-2 s/o e s/n de formaldeido de acidos carbapenem-3-carboxilicos e seu uso como antibioticos e inibidores de beta-lactamase

Info

Publication number
PT1100800E
PT1100800E PT99936602T PT99936602T PT1100800E PT 1100800 E PT1100800 E PT 1100800E PT 99936602 T PT99936602 T PT 99936602T PT 99936602 T PT99936602 T PT 99936602T PT 1100800 E PT1100800 E PT 1100800E
Authority
PT
Portugal
Prior art keywords
inhibitors
derivatives
formaldeido
acetary
carbapenem
Prior art date
Application number
PT99936602T
Other languages
English (en)
Portuguese (pt)
Inventor
Rudolf Pfaendler Prof Hans
Original Assignee
Rudolf Pfaendler Prof Hans
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rudolf Pfaendler Prof Hans filed Critical Rudolf Pfaendler Prof Hans
Publication of PT1100800E publication Critical patent/PT1100800E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
PT99936602T 1998-07-28 1999-07-23 Novos derivados acetais c-2 s/o e s/n de formaldeido de acidos carbapenem-3-carboxilicos e seu uso como antibioticos e inibidores de beta-lactamase PT1100800E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98114067A EP0976752A1 (en) 1998-07-28 1998-07-28 C-2 S/O- and S/N-Formaldehyde acetal derivatives of carbapenem antibiotics

Publications (1)

Publication Number Publication Date
PT1100800E true PT1100800E (pt) 2003-11-28

Family

ID=8232355

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99936602T PT1100800E (pt) 1998-07-28 1999-07-23 Novos derivados acetais c-2 s/o e s/n de formaldeido de acidos carbapenem-3-carboxilicos e seu uso como antibioticos e inibidores de beta-lactamase

Country Status (17)

Country Link
US (1) US6482818B2 (enExample)
EP (2) EP0976752A1 (enExample)
JP (1) JP4598273B2 (enExample)
KR (1) KR20010086351A (enExample)
CN (1) CN1154649C (enExample)
AT (1) ATE243696T1 (enExample)
AU (1) AU760249B2 (enExample)
CA (1) CA2338776C (enExample)
DE (1) DE69909098T2 (enExample)
ES (1) ES2203164T3 (enExample)
HU (1) HUP0102729A3 (enExample)
IL (1) IL141114A (enExample)
MX (1) MXPA01000905A (enExample)
NZ (1) NZ509578A (enExample)
PT (1) PT1100800E (enExample)
WO (1) WO2000006574A1 (enExample)
ZA (1) ZA200100737B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2576677A1 (en) * 2004-08-23 2006-03-02 Sicor, Inc. Synthesis of idarubin aglycone
JP5276653B2 (ja) 2007-05-21 2013-08-28 ハンス・ルドルフ・プフェンドラー カルバペネム類を含む殺菌性抗mrsa活性医薬組成物
CN101412718B (zh) * 2007-10-19 2011-04-27 山东轩竹医药科技有限公司 含有硫基杂环胺甲酰基的碳青霉烯衍生物
CN103059028B (zh) * 2013-01-30 2014-05-07 山东罗欣药业股份有限公司 一种替比培南匹伏酯的制备方法
CN114957258A (zh) * 2021-02-25 2022-08-30 华东理工大学 基于碳青霉烯结构的广谱丝氨酸β-内酰胺酶抑制剂的合成及其在耐药细菌抑制中的应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58116485A (ja) * 1981-12-29 1983-07-11 Shionogi & Co Ltd 新規抗生物質カルバペネム誘導体およびその製造法
GB2116540B (en) * 1981-11-10 1985-07-17 Shionogi & Co Pluracidomycin b c and d and analogs thereof their production and a microorganism for use therein
JPS58124785A (ja) * 1982-01-20 1983-07-25 Shionogi & Co Ltd プルラシドマイシンbおよびcのデオキシ体ならびにその製造法
JPS6054387A (ja) * 1983-08-03 1985-03-28 メルク エンド カムパニ− インコ−ポレ−テツド チエナマイシンの誘導体製造法
CA1285940C (en) * 1984-07-02 1991-07-09 Merck & Co., Inc. Carbapenems having a 2-quaternary heteroarylalkylthio substituent
IE851586L (en) * 1984-07-02 1986-01-02 Interchem Internat S A I methylcarbapenems having a 2-quaternary¹heteroarylalkylthio substituent
JPS63255283A (ja) * 1987-04-11 1988-10-21 Nippon Redarii Kk (1r,5s,6s)−2−〔(3−置換イミダゾリニウム−1−イル)アルキル〕チオ−6−〔(r)−1−ヒドロキシエチル〕−1−メチル−カルバペネム−3−カルボキシレ−ト
US5116833A (en) * 1990-10-19 1992-05-26 Bristol-Myers Squibb Company Antibiotic c-3 dithioacetal-substituted carbapenem compounds, compositions, and methods of use thereof

Also Published As

Publication number Publication date
HUP0102729A2 (hu) 2002-01-28
KR20010086351A (ko) 2001-09-10
JP4598273B2 (ja) 2010-12-15
AU5163999A (en) 2000-02-21
ZA200100737B (en) 2002-07-25
EP0976752A1 (en) 2000-02-02
IL141114A (en) 2004-02-08
CN1311790A (zh) 2001-09-05
EP1100800B1 (en) 2003-06-25
MXPA01000905A (es) 2002-06-04
AU760249B2 (en) 2003-05-08
EP1100800A1 (en) 2001-05-23
DE69909098D1 (de) 2003-07-31
CA2338776C (en) 2008-04-29
US20010031749A1 (en) 2001-10-18
NZ509578A (en) 2003-06-30
WO2000006574A1 (en) 2000-02-10
CN1154649C (zh) 2004-06-23
ES2203164T3 (es) 2004-04-01
IL141114A0 (en) 2002-02-10
HUP0102729A3 (en) 2002-09-30
CA2338776A1 (en) 2000-02-10
JP2002521484A (ja) 2002-07-16
ATE243696T1 (de) 2003-07-15
US6482818B2 (en) 2002-11-19
DE69909098T2 (de) 2004-04-08

Similar Documents

Publication Publication Date Title
AU689304B2 (en) Quinazoline derivative
PT846686E (pt) Derivados de 1-fenil-pirazole e suas utilizacoes como agentes parasiticidas
ATE448226T1 (de) Aza heterocyclische derivate und ihre therapeutische verwendung
LU91162I2 (fr) Aloxi-Palonosétrone et ses dérivés pharmaceutiquement acceptables.
ES2322602T3 (es) Compuestos heterotetraciclicos condensados y su uso como inhibidor de polimerasa del vhc.
NO970151L (no) Oksygeninneholdende heterocykliske forbindelser
DK0976748T3 (da) Pyrrolidinderivater med phospholispase A2-hæmmende aktivitet
EP1642880A4 (en) PROTEIN INHIBITORS OF THE HSP90 FAMILY
DK0452873T3 (da) 1,8-naphthyridin-2-on-derivater
DK1008592T3 (da) Cykliske amidderivater, som inhiberer cathepsin K
DK0657422T3 (da) Naphthyloxyeddikesyrederivater som PEG2-agonister og -antagonister
NO20004517L (no) Benzofurylpyron-derivater
ATE276257T1 (de) Pyrazinonderivate
DK0641770T3 (da) Hidtil ukendte forbindelser med blodpladeaggegationsinhiberende aktivitet
ATE243696T1 (de) C-2 s/o- und s/n-formaldehydacetal-derivate von carbapenem-3-carbonsäuren und deren verwendung als antibiotika und beta-lactamas-inhibitoren
NO20051282L (no) Antitumorale analoger av lamellariner.
ES2106439T3 (es) 5-(piperazinilalquil)-1,5-benzotiazepinonas utiles como antagonistas de calcio.
DE60130916D1 (de) Neue beta-lactamverbindungen und verfahren zu deren herstellung
ATE258934T1 (de) Azaindol derivate und ihre verwendung als antithrombotische wirkstoffe
NO20053997L (no) Oligosaccharidderivat
DE69124017D1 (de) Heterocyclische Derivate
NO20053302L (no) Imidazolderivater med affinitet for alfa 2-reseptoraktivitet.
EP1219608A4 (en) PYRIMID DERIVATIVES, METHOD FOR PRODUCING THE DERIVATIVES AND MEDICINES CONTAINING IT AS THE ACTIVE COMPONENT
ITMI20032102A1 (it) Composti peptidomimetici, procedimento stereoselettivo per la loro preparazione, loro uso come intermedi di sintesi di derivati biologicamente attivi.
FI951828A0 (fi) Imidatsopyridiinijohdokset ja menetelmä niiden valmistamiseksi